Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by John Pemberton. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by John Pemberton or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

20 — Standardization of Testing CGM Performance: The Nuts and Bolts with Stefan Pleus of the IFCC

58:01
 
Share
 

Manage episode 509223279 series 3645892
Content provided by John Pemberton. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by John Pemberton or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Suggest guests or get in contact

Episode 20 — Standardization of Testing CGM Performance: The Nuts and Bolts

With Dr. Stefan Pleus (Institut für Diabetes-Technologie, Universität Ulm; Chair of the IFCC Working Group on CGM).

Full show notes and FAQ, and consider buying me a Coffee to keep pumping.

In this episode, we go deep into the future of continuous glucose monitoring (CGM) standards. Dr. Pleus explains why the FDA iCGM framework (2018) is no longer enough, what a robust international standard would look like, and why ISO standardisation by 2030 is essential if CGM is to:

  • Be a reliable basis for insulin dosing
  • Act as a trusted comparator in clinical trials
  • Enable screening and early diagnosis of type 1 diabetes
  • Provide consistency across devices for people with diabetes

Key insights from Stefan Pleus:

  • Study design matters: if you avoid rapid glucose changes, results look good — but that’s not real life.
  • Stress-testing requires minimum data in low, high, and rapid-change zones.
  • Every comparator has bias: retrospective correction is essential to align results across manufacturers.
  • With better study designs, today’s systems may appear less accurate — but only because we’re finally testing them properly.
  • Global alignment between FDA and Europe is needed; without it, innovation risks stalling.

Why this matters:

Without standardisation, insulin dosing, clinical trials, and diagnostics will remain inconsistent across devices. The 2030 opportunity is a global, reproducible framework that ensures fairness for users, clarity for clinicians, and valid results for researchers.

Full show notes and FAQ, and consider buying me a Coffee to keep pumping.

For collaboration, partnerships, or press enquiries:
John Pemberton[email protected]

For creative, social, and production enquiries:
Anjanee Kohli[email protected]

Buy The Glucose Never Lies® a Coffee — help us stay independent and ad-free:

We’re an independent, evidence-based platform — free from sponsorships and commercial bias. Your support helps us keep translating science into understanding.

Follow The Glucose Never Lies®
🌐 Website

📸 Instagram
💼 LinkedIn
👤 LinkedIn — John Pemberton
🐦 X / Twitter
© The Glucose Never Lies Ltd

  continue reading

24 episodes

Artwork
iconShare
 
Manage episode 509223279 series 3645892
Content provided by John Pemberton. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by John Pemberton or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Suggest guests or get in contact

Episode 20 — Standardization of Testing CGM Performance: The Nuts and Bolts

With Dr. Stefan Pleus (Institut für Diabetes-Technologie, Universität Ulm; Chair of the IFCC Working Group on CGM).

Full show notes and FAQ, and consider buying me a Coffee to keep pumping.

In this episode, we go deep into the future of continuous glucose monitoring (CGM) standards. Dr. Pleus explains why the FDA iCGM framework (2018) is no longer enough, what a robust international standard would look like, and why ISO standardisation by 2030 is essential if CGM is to:

  • Be a reliable basis for insulin dosing
  • Act as a trusted comparator in clinical trials
  • Enable screening and early diagnosis of type 1 diabetes
  • Provide consistency across devices for people with diabetes

Key insights from Stefan Pleus:

  • Study design matters: if you avoid rapid glucose changes, results look good — but that’s not real life.
  • Stress-testing requires minimum data in low, high, and rapid-change zones.
  • Every comparator has bias: retrospective correction is essential to align results across manufacturers.
  • With better study designs, today’s systems may appear less accurate — but only because we’re finally testing them properly.
  • Global alignment between FDA and Europe is needed; without it, innovation risks stalling.

Why this matters:

Without standardisation, insulin dosing, clinical trials, and diagnostics will remain inconsistent across devices. The 2030 opportunity is a global, reproducible framework that ensures fairness for users, clarity for clinicians, and valid results for researchers.

Full show notes and FAQ, and consider buying me a Coffee to keep pumping.

For collaboration, partnerships, or press enquiries:
John Pemberton[email protected]

For creative, social, and production enquiries:
Anjanee Kohli[email protected]

Buy The Glucose Never Lies® a Coffee — help us stay independent and ad-free:

We’re an independent, evidence-based platform — free from sponsorships and commercial bias. Your support helps us keep translating science into understanding.

Follow The Glucose Never Lies®
🌐 Website

📸 Instagram
💼 LinkedIn
👤 LinkedIn — John Pemberton
🐦 X / Twitter
© The Glucose Never Lies Ltd

  continue reading

24 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play